---
title: "Solventum (SOLV) stock listing, news and investor profile"
url: "https://aibio.space/companies/solventum/"
publisher: "aibio.space (Biotech Investor Relations News)"
summary: "Solventum Corp (NYSE: SOLV), United States. Listing facts, related biotech companies and news on aibio.space."
---

SOLV Solventum Corp NYSE · United States

# Solventum (SOLV) news

Solventum Corp is a public biotech or pharmaceutical company listed on NYSE under the ticker SOLV, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

## Latest Solventum news

We have not published a story on Solventum yet. When there is news, it will appear here.

## Solventum at a glance

- **Ticker**: SOLV

- **Listing**: NYSE

- **Country**: United States

- **Cash, Jun 30, 2026**: $403.0 million

### Related companies

- [CERUS CORP](https://aibio.space/companies/cerus/) NASDAQ: CERS
- [SYNLOGIC, INC.](https://aibio.space/companies/synlogic/) OTC: SYBX
- [ENvue Medical](https://aibio.space/companies/envue-medical/) OTC: FEED
- [Quantum Cyber](https://aibio.space/companies/quantum-cyber-n-v/) NASDAQ: QUCY
- [NATURES SUNSHINE PRODUCTS INC](https://aibio.space/companies/natures-sunshine-products/) NASDAQ: NATR
- [KORU Medical Systems](https://aibio.space/companies/koru-medical-systems/) NASDAQ: KRMD
- [IQVIA HOLDINGS INC.](https://aibio.space/companies/iqvia/) NYSE: IQV
- [Odyssey Health](https://aibio.space/companies/odyssey-health/) OTC: ODYY

### Also on NYSE

- [Evommune](https://aibio.space/companies/evommune/) EVMN
- [Hercules Capital](https://aibio.space/companies/hercules-capital/) HTGC
- [VOLITIONRX LTD](https://aibio.space/companies/volitionrx/) VNRX
- [Abbott Laboratories](https://aibio.space/companies/abbott-laboratories/) ABT
- [METTLER TOLEDO INTERNATIONAL INC/](https://aibio.space/companies/mettler-toledo-international/) MTD
- [Inspire Medical Systems](https://aibio.space/companies/inspire-medical-systems/) INSP

## Solventum annual financials

| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | [$8.32 billion](https://www.sec.gov/Archives/edgar/data/1964738/000196473826000007/) | [$8.25 billion](https://www.sec.gov/Archives/edgar/data/1964738/000196473826000007/) |
| Research and development | [$739.0 million](https://www.sec.gov/Archives/edgar/data/1964738/000196473826000007/) | [$775.0 million](https://www.sec.gov/Archives/edgar/data/1964738/000196473826000007/) |
| Net income (loss) | [$1.56 billion](https://www.sec.gov/Archives/edgar/data/1964738/000196473826000007/) | [$479.0 million](https://www.sec.gov/Archives/edgar/data/1964738/000196473826000007/) |
| Cash from operations | [$369.0 million](https://www.sec.gov/Archives/edgar/data/1964738/000196473826000007/) | [$1.19 billion](https://www.sec.gov/Archives/edgar/data/1964738/000196473826000007/) |
| Cash and equivalents | [$878.0 million](https://www.sec.gov/Archives/edgar/data/1964738/000196473826000047/) | [$762.0 million](https://www.sec.gov/Archives/edgar/data/1964738/000196473826000007/) |

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $403.0 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

## Questions about Solventum

What is the ticker symbol of Solventum?

Solventum Corp trades under the ticker SOLV on NYSE.

Where is Solventum listed?

Solventum Corp is listed on NYSE.

Which country or territory is Solventum listed under?

Our directory records Solventum Corp under United States.

Does aibio.space cover Solventum?

aibio.space lists Solventum Corp among 2,820 public biotech companies and publishes its news here as stories appear.

What was Solventum's revenue last year?

$8.32 billion for the fiscal year ended Dec 31, 2025, as reported to the SEC.

Is Solventum profitable?

Solventum Corp reported net income of $1.56 billion for the fiscal year ended Dec 31, 2025, and generated $369.0 million of cash from operations, per its annual report to the SEC.

How much does Solventum spend on research and development?

$739.0 million in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does Solventum have?

$403.0 million in cash at Jun 30, 2026, per its 10-Q.

## Investor discussion: Solventum

Members talk about Solventum (SOLV). Reader posts, not aibio.space reporting, and not investment advice.

Rules

1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
2. **Say whether you hold the stock.** Every post states long, short or no position.
3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you.
4. **No buy or sell calls and no price targets.**
5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them.
6. **No personal details and no spam.** No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion).

## Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Solventum, newest first. Each line links the filing it comes from.

1. 2026-06-05 Legal Disclosed a shareholder lawsuit, subpoena or other legal matter. SEC Form 8-K (Items 8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1964738/000196473826000036/solv-20260602.htm)

## Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NYSE:SOLV on TradingView](https://www.tradingview.com/symbols/NYSE-SOLV/).

## Listing details

Solventum Corp is a public biotech or pharmaceutical company listed on NYSE under the ticker SOLV, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

- **Company**: Solventum Corp

- **Ticker**: SOLV

- **Listing**: NYSE

- **Country or territory**: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/).

Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/).

Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update)

---
Source page: https://aibio.space/companies/solventum/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Solventum (SOLV) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/solventum/
